Back to News
Market Impact: 0.2
Thursday's ETF Movers: ARKG, TAN
Source: Nasdaq
Healthcare & BiotechMarket Technicals & Flows
The ARK Genomic Revolution ETF rose about 2.6% in Thursday trading, outperforming other ETFs. Key contributors included CareDx, up roughly 13.5%, and Twist Bioscience, up about 10.6%, signaling strong risk appetite for select genomic and biotech equities.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.32
Ticker Sentiment
CDNA0.62
TWST0.52
More News
- Nasdaq defies Nvidia impact as Huang faces espionage affair probe
- Jensen Huang’s $21 billion net worth in AI rout—Nvidia’s recovery will be ‘capped’ after he admitted affair with alleged Chinese spy
- Key AI chip index just broke its long-term trendline. What history says happens next
- Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
- Weekend trading of Nvidia scandal shines light on new financial products
- Why is Nvidia’s Jensen Huang at the centre of a US-China spy scandal?